Potential impact of combined influenza and pneumococcal vaccines on the severity of respiratory illness in COVID-19 infection among type 2 diabetic patients.

Clin Exp Med · 2023 · PMC8783660 · PMID 35066730

Europe PMC DOI

hedged sentence

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantp = 0.0001actually significant

24.15 ± 5.43 pre-vaccination = 0.0001) and highly significant reduction when compared to the control group presented with respiratory symptoms (14.1 ± 2.7 vs. 26.5 ± 7.45, p = 0.0001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.